[go: up one dir, main page]

IS5166A - Crystallized aqueous sodium salt of (E) -4,6-dichloro-3- (2-oxo-1-phenylpyrrolidin-3-ylidene methyl) -1H-indole-2-carboxylic acid - Google Patents

Crystallized aqueous sodium salt of (E) -4,6-dichloro-3- (2-oxo-1-phenylpyrrolidin-3-ylidene methyl) -1H-indole-2-carboxylic acid

Info

Publication number
IS5166A
IS5166A IS5166A IS5166A IS5166A IS 5166 A IS5166 A IS 5166A IS 5166 A IS5166 A IS 5166A IS 5166 A IS5166 A IS 5166A IS 5166 A IS5166 A IS 5166A
Authority
IS
Iceland
Prior art keywords
phenylpyrrolidin
indole
dichloro
oxo
carboxylic acid
Prior art date
Application number
IS5166A
Other languages
Icelandic (is)
Inventor
Cimarosti Zadeo
Maragni Paolo
Original Assignee
Glaxo Wellcome Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Spa filed Critical Glaxo Wellcome Spa
Publication of IS5166A publication Critical patent/IS5166A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IS5166A 1997-03-05 1999-08-27 Crystallized aqueous sodium salt of (E) -4,6-dichloro-3- (2-oxo-1-phenylpyrrolidin-3-ylidene methyl) -1H-indole-2-carboxylic acid IS5166A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9704498.6A GB9704498D0 (en) 1997-03-05 1997-03-05 Chemical compound
PCT/EP1998/001146 WO1998039327A1 (en) 1997-03-05 1998-03-03 Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid

Publications (1)

Publication Number Publication Date
IS5166A true IS5166A (en) 1999-08-27

Family

ID=10808697

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5166A IS5166A (en) 1997-03-05 1999-08-27 Crystallized aqueous sodium salt of (E) -4,6-dichloro-3- (2-oxo-1-phenylpyrrolidin-3-ylidene methyl) -1H-indole-2-carboxylic acid

Country Status (29)

Country Link
EP (1) EP0966463A1 (en)
JP (1) JP2001513796A (en)
KR (1) KR20000075907A (en)
CN (1) CN1249750A (en)
AP (1) AP9901637A0 (en)
AR (1) AR011178A1 (en)
AU (1) AU6825198A (en)
BG (1) BG103779A (en)
BR (1) BR9808305A (en)
CA (1) CA2282851A1 (en)
CO (1) CO4940415A1 (en)
EA (1) EA199900710A1 (en)
EE (1) EE9900387A (en)
GB (1) GB9704498D0 (en)
HR (1) HRP980114A2 (en)
HU (1) HUP0002109A2 (en)
ID (1) ID24207A (en)
IL (1) IL131489A0 (en)
IS (1) IS5166A (en)
NO (1) NO994303L (en)
NZ (1) NZ337315A (en)
OA (1) OA11154A (en)
PE (1) PE51399A1 (en)
PL (1) PL335652A1 (en)
SK (1) SK119699A3 (en)
TR (1) TR199902117T2 (en)
WO (1) WO1998039327A1 (en)
YU (1) YU43499A (en)
ZA (1) ZA981791B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9704499D0 (en) * 1997-03-05 1997-04-23 Glaxo Wellcome Spa Method of manufacture
GB9825988D0 (en) * 1998-11-27 1999-01-20 Pfizer Ltd Indole derivatives
GB9915231D0 (en) 1999-06-29 1999-09-01 Pfizer Ltd Pharmaceutical complex
US9737531B2 (en) 2012-07-12 2017-08-22 Glytech, Llc Composition and method for treatment of depression and psychosis in humans
MX393950B (en) 2017-06-12 2025-03-24 Glytech Llc COMPOSITION AND METHOD FOR THE TREATMENT OF DEPRESSION AND PSYCHOSIS IN HUMANS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9321221D0 (en) * 1993-10-14 1993-12-01 Glaxo Spa Heterocyclic compounds

Also Published As

Publication number Publication date
JP2001513796A (en) 2001-09-04
EP0966463A1 (en) 1999-12-29
IL131489A0 (en) 2001-01-28
KR20000075907A (en) 2000-12-26
ID24207A (en) 2000-07-13
YU43499A (en) 2000-12-28
PE51399A1 (en) 1999-06-07
AU6825198A (en) 1998-09-22
CO4940415A1 (en) 2000-07-24
CN1249750A (en) 2000-04-05
SK119699A3 (en) 2000-05-16
NO994303L (en) 1999-11-03
PL335652A1 (en) 2000-05-08
EA199900710A1 (en) 2000-04-24
HUP0002109A2 (en) 2001-04-28
BR9808305A (en) 2000-05-16
EE9900387A (en) 2000-04-17
NO994303D0 (en) 1999-09-03
ZA981791B (en) 1999-09-03
OA11154A (en) 2003-04-16
AR011178A1 (en) 2000-08-02
NZ337315A (en) 2001-02-23
AP9901637A0 (en) 1999-09-30
TR199902117T2 (en) 2000-03-21
WO1998039327A1 (en) 1998-09-11
GB9704498D0 (en) 1997-04-23
BG103779A (en) 2000-06-30
CA2282851A1 (en) 1998-09-11
HRP980114A2 (en) 1998-12-31

Similar Documents

Publication Publication Date Title
DK0991641T3 (en) Crystalline form of omeprazole sodium salt
NO20005084L (en) Heterocyclic glycyl <beta> -alanine derivatives as vitronectin antagonists
NO20013665L (en) Potassium salt of (S) -omeprazole
PT1163237E (en) AMIDA DERIVATIVES
EE200000720A (en) Novel 3-aryl-2-hydroxypropanoic acid derivative (I)
AR028280A1 (en) DERIVATIVES OF 2-AMINO-3- (RENT) -PIRIMIDONA
DK1386921T3 (en) Intermediates for the preparation of anti-thrombotic 4H-cycolopenta-1,3-dioxole derivatives
DK1163207T3 (en) Improved process for the preparation of non-hygroscopic salts of L (-) - carnitine
DE69900356D1 (en) Nitro isourea derivatives
NO20013684D0 (en) Substituted phenethylamine derivatives
IS5562A (en) New dihydroxyhexanoic acid derivatives
ATE299876T1 (en) INDOLE DERIVATIVES
IS5166A (en) Crystallized aqueous sodium salt of (E) -4,6-dichloro-3- (2-oxo-1-phenylpyrrolidin-3-ylidene methyl) -1H-indole-2-carboxylic acid
DK0975594T3 (en) Process for the preparation of indole derivatives
NO20020306D0 (en) indole derivatives
NO20002904L (en) (E) -3- [1-N-butyl-5- [2- (2-carboxylphenyl) methoxy-4-chlorophenyl] -1H-pyrazol-4-yl] -2 - [(5-methoxy-2,3 -dihydrobenzofuran-6-yl) methyl] -prop-2-enoic acid monoagrinin salt
EE200100017A (en) New salts of N-tert-butylhydroxylamine
IT1307734B1 (en) CARTRIDGE FOR DIALYSIS CONTAINING SODIUM BICARBONATE.
DK1140984T3 (en) Selective inhibitors of MMP-12
HK1022899A (en) Crystalline hydrated sodium salt of (e)-4, 6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid
ATE414059T1 (en) CRYSTALLINE FORM OF THE SODIUM SALT OF 5-CHLORINE-2-METHOXY-N-(2-(4-METHOXY-3-METHYLAMINOTHIOCARBONYLAMINOSULFONYLPHENYL)ETHY )BNZAMIDE
DK0971919T3 (en) Process for Preparation of 4H-4-Oxo-Quinolizine-3-Carboxylic Acid Derivatives
DK0989113T3 (en) Process for Preparation of 2-Aminomalonic Acid Derivatives